{"id":745707,"date":"2021-06-15T13:00:00","date_gmt":"2021-06-15T13:00:00","guid":{"rendered":"https:\/\/www.pm360online.com\/?guid=f54693bddf5402d8fecbe0dbf558455d"},"modified":"2021-06-15T13:00:00","modified_gmt":"2021-06-15T13:00:00","slug":"neurometrix-reports-that-quell-technology-is-to-be-evaluated-for-neuromyelitis-optica-spectrum-disorder-nmosd-in-a-randomized-controlled-trial-3","status":"publish","type":"post","link":"https:\/\/www.pm360online.com\/neurometrix-reports-that-quell-technology-is-to-be-evaluated-for-neuromyelitis-optica-spectrum-disorder-nmosd-in-a-randomized-controlled-trial-3\/","title":{"rendered":"NeuroMetrix Reports that Quell\u00ae Technology is to be Evaluated for Neuromyelitis Optica Spectrum Disorder (NMOSD) in a Randomized Controlled Trial"},"content":{"rendered":"<p><![CDATA[WOBURN, Mass., June  15, 2021  (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that Quell technology will be used in a double-blinded, randomized, sham-controlled trial to determine whether transcutaneous electrical nerve stimulation (TENS) is an effective, acceptable and feasible method of pain relief in patients with NMOSD. The principal investigator is Michael Levy, M.D., Ph.D., Director, NMO Clinic and Research Laboratory, Massachusetts General Hospital, Boston, MA.]]><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":74553,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[71350,71361],"tags":[],"_links":{"self":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts\/745707"}],"collection":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/users\/74553"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/comments?post=745707"}],"version-history":[{"count":0,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts\/745707\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/media?parent=745707"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/categories?post=745707"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/tags?post=745707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}